Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-8-31
pubmed:abstractText
Tumor-initiating cells (TICs) are defined by their ability to form tumors after xenotransplantation in immunodeficient mice and appear to be relatively rare in most human cancers. Recent data in melanoma indicate that the frequency of TICs increases dramatically via more permissive xenotransplantation conditions, raising the possibility that the true frequency of TICs has been greatly underestimated in most human tumors. We compared the growth of human pancreatic, non-small cell lung, and head and neck carcinomas in NOD/SCID and NSG mice. Although TIC frequency was detected up to 10-fold higher in NSG mice, it remained low (<1 in 2500 cells) in all cases. Moreover, aldehyde dehydrogenase-positive (ALDH(+)) and CD44(+)CD24(+) cells, phenotypically distinct cells enriched in TICs, were equally tumorigenic in NOD/SCID and NSG mice. Our findings demonstrate that TICs are rare in these cancers and that the identification of TICs and their frequency in other human malignancies should be validated via primary tumors and highly permissive xenotransplantation conditions.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-12629218, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-14047954, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-14630803, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-15549107, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-16230395, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-16920987, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-16990346, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-17210912, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-17283135, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-17548814, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-17641192, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-18202660, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-18242515, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-18765555, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-19052619, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-19208848, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-19567251, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-19737509, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-20164446, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-20596026, http://linkedlifedata.com/resource/pubmed/commentcorrection/20804964-7509044
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1875-9777
pubmed:author
pubmed:copyrightInfo
Copyright 2010 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
3
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
279-82
pubmed:dateRevised
2011-9-13
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Tumor-initiating cells are rare in many human tumors.
pubmed:affiliation
Latner Thoracic Surgery Research Laboratories, Toronto General Research Institute, University of Toronto, University Health Network, Toronto, Ontario MG5 1L7, Canada.
pubmed:publicationType
Letter, Research Support, Non-U.S. Gov't